XML 12 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Gain (Loss) [Member]
Beginning balance at Dec. 31, 2022 $ 110,903 $ 43 $ 262,496 $ (151,605) $ (31)
Beginning balance, shares at Dec. 31, 2022   43,269,200      
Stock-based compensation expense 1,833   1,833    
Unrealized gain (loss) on marketable securities 31       31
Net loss (6,526)     (6,526)  
Ending balance at Mar. 31, 2023 106,241 $ 43 264,329 (158,131)  
Ending balance, shares at Mar. 31, 2023   43,269,200      
Beginning balance at Dec. 31, 2023 81,720 $ 43 270,150 (188,554) 81
Beginning balance, shares at Dec. 31, 2023   43,909,069      
Issuance of common stock, net $ 161,756 $ 20 161,736    
Issuance of common stock, net, shares   19,736,842      
Vesting of restricted stock units   $ 1 (1)    
Vesting of restricted stock units, shares   153,750      
Exercise of stock options, shares 356 356      
Stock-based compensation expense $ 2,128   2,128    
Unrealized gain (loss) on marketable securities (106)       (106)
Net loss (14,654)     (14,654)  
Ending balance at Mar. 31, 2024 $ 230,844 $ 64 $ 434,013 $ (203,208) $ (25)
Ending balance, shares at Mar. 31, 2024   63,800,017